ArticleJapanese journal of clinical oncology2015

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

Hideyuki Akaza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.